DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: A006620)
Health Care · Pharmaceuticals · KR
₩3,690.00
-5.75% today · -26.3% 1Y
DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: A006620) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $72.00M.
Over the last twelve months the share price has lost 26.3%, trading between 3.48K and 6.39K.
Tweenvest scores DongKoo Bio & Pharma Co., Ltd. across four factors: quality 52/100, value 45/100. Its strongest factor is quality.
A006620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $72.00M
- Revenue (TTM)
- $155.90M
- P/E
- 3.10
- EPS
- 1,191.87
- Dividend yield
- —
- Beta (5Y)
- 0.37
- 52-week high
- ₩6,390.00
- 52-week low
- ₩3,485.00
- Avg volume (3M)
- —
- Shares outstanding
- 27.04M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.35 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.38 | +0.09% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.17 | -0.18% |
| Roche Holding AGSWX: ROP | $371.62B | CHF374.20 | +0.11% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.68 | -0.87% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.